News

Webinar – full view

June 1, 2021 – Cuxhaven, Germany On May 27th Dr. Heike Bigmore (Vaxxinova) and Dr. Twan van Gerwe (EW Nutrition) focussed on the role of vaccination in effective antibiotic reduction programs in production animals. The seminar was hosted by EW Nutrition. The full seminar is available via this link.
Read more →

Webinar Autogenous Vaccines on May 27th

May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH,  will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]
Read more →

Article on autogenous vaccines in “Boerderij”

Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.  
Read more →

We strenghten our team

Vaxxinova is very pleased to announce that Dr. Heike Bigmore (née Scharr) has joined Vaxxinova Autogenous Vaccines GmbH as Key Account Manager for Europe on April 29th 2020.  Her primary focus will be on the poultry business. Heike is a very experienced veterinary professional and during her 30-year career she has built a broad expertise […]
Read more →

Further development of autogenous vaccines against Streptococcus suis

Infections with Streptococcus suis are still a big problem worldwide. In addition to management measures to reduce the pathogen pressure in the farm, autogenous (farm-specific) vaccines have been crucial in the fight against S. suis infections for many years. At Vaxxinova, the antigen production and formulation has now been further developed to prevent infections with […]
Read more →

Control of fowl adenovirus (FAdV) with autogenous vaccines

In today’s poultry industry FAdV is mostly seen in young chickens, especially broilers. In these cases, Inclusion body hepatitis (IBH) and Adenoviral gizzard erosions (AGE) are the predominant clinical picture leading to high economic losses worldwide. Inactivated FAdV autogenous vaccines are used to interrupt vertical transmission of FAdV and to deliver maternal antibodies to progenies. […]
Read more →

Customer Service department moved to Cuxhaven

We are pleased to inform you that our Customer Service department has moved in February from our site in Münster to our site in Cuxhaven. With this step, we have Customer Service directly on the premises where the autogenous vaccines are manufactured. From 01 March 2019 onwards, please use the telephone- and fax-numbers as below. […]
Read more →

Niedersächsische Tierärztetag (veterinarian congress) in Hanover

From January 24 to 26, 2019, the Niedersächsische Tierärztetag (veterinarian congress) took place in Hanover. Vaxxinova was on site with a seminar on autogenous vaccines in swine and a lecture on M. hyorhinis and M. hyosynoviae. Dr. Adrian Lührs presented the possibilities and limitations of using autogenous vaccines for mycoplasma and streptococcal infections. In the presentation in […]
Read more →

Vaxxinova receives Animal Pharm Award for Best European Company 2018

Nijmegen, The Netherlands, 18 January 2019 Vaxxinova is pleased and honored to receive the Animal Pharm Award for Best European Company 2018. Vaxxinova is glad to see that the importance of disease prevention and the role that vaccines play in this, is recognized. As Animal Pharm indicates, “The judging panel for the awards liked the […]
Read more →

New at Vaxxinova diagnostics

Expanded genotyping of Actinobacillus pleuropneumoniae (APP) – In addition to classic APP serotypes 2, 9/11, 5 and 8, non-typeable strains have also been reported in 10% of the cases in the past. Due to expansion of molecular-biological typing, serotypes 1 to 18 can now be distinguished at Vaxxinova. This can help to confirm the entry […]
Read more →